Yahoo Web Search

    • 10-Q: TRACON PHARMACEUTICALS, INC.

      Market Watch· 5 days ago

      (Janssen) in September 2016, and TJ004309, which is a CD73 antibody in Phase 1 clinical development for the treatment of solid tumors, that we licensed from I-Mab...

    • 10-Q: MEIRAGTX HOLDINGS PLC

      Market Watch· 5 days ago

      ("Janssen"), one of the Janssen Pharmaceuticals Companies of Johnson & Johnson (the "Collaboration and License Agreement"). As of...